Alpha Teknova (TKNO) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Alpha Teknova

NasdaqGM•Healthcare•Drug Manufacturers - Specialty & Generic

$6.88-0.04(-0.01%)Pre-market

Market Cap

$399.58M

P/S

9.1x

P/B

6.4x

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

How this company scores

AverageMetricSide Score: 52/100

Strongest: Growth (19/25); weakest: Cash & Earnings Quality (6/25).

Profitability13/25

Growth19/25

Balance Sheet & Red Flags14/25

Cash & Earnings Quality6/25

Strengths

Low leverageProfit converts from growthConsistent growthImproving margins

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/S · 9.1x5y range 1.6x – 11.0x

Currently above its 18-quarter median.

P/B · 6.4x5y range 0.7x – 6.4x

Currently above its 20-quarter median.

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

Free cash flow has been negative in 8 of the last 8 quarters — earnings are not translating to cash.

Price & Volume

Market Cap $399.58M

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $43.70M
Q. Revenue: $12.19M
TTM EBITDA: $-9.47M
TTM Op. Income: $-15.81M
Q. Op. Income: $-2.89M
TTM Net Income: $-16.77M
Q. Net Income: $-3.17M
EPS: $-0.06
Shares Out.: $53.63M

$43.70M in TTM revenue grew 12.3% YoY, reaching $12.19M last quarter. TTM EBITDA of $-9.47M and TTM operating income of $-15.81M show growth is flowing through to the bottom line. However, net income is negative at $16.77M — growth is not yet reaching the bottom line. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 40.1%
EBITDA Margin: -10.6%
Op. Margin: -23.7%
Net Margin: -26.0%

Op. margin of -23.7% is up 9.2% YoY — cost efficiency is improving. Net margin at -26.0% and gross margin of 40.1% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 9.1x
P/B Ratio: 6.4x

P/S of 9.1x and P/B of 6.4x.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $95.88M
Cash: $6.00M
Long-Term Debt: $13.22M
Book Value: $62.60M
D/E Ratio: 0.2
Debt/EBITDA: N/A

With $95.88M in assets and $13.22M in long-term debt, D/E is 0.2and book value is $62.60M — a conservative capital structure with a cushion to weather downturns. Across the last 8 quarters, debt/equity has risen for 6 consecutive quarters — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $-471,000
TTM Free Cash Flow: $-7.35M
FCF Margin: -16.8%
FCF / Net Income: 0.4

TTM FCF of $-7.35M on $-471,000 in operating cash flow. The FCF / Net Income ratio of 0.4x means cash covers only part of net income — earnings quality needs attention. Across the last 8 quarters, free cash flow has risen for 7 consecutive quarters — an improving trend.